Insider · CIK 0001773588
Adam J. Townsend
officer
Files at APLS (Apellis Pharmaceuticals, Inc.). First filing Jan 14, 2025, latest Jan 30, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $265k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Apellis Pharmaceuticals, Inc. | $21k 695 shares | -1% | - | |
| 40Moderate | Apellis Pharmaceuticals, Inc. | $101k 3,323 shares | -4% | - | |
| 38Weak | Apellis Pharmaceuticals, Inc. | $66k 2,201 shares | -2% | - | |
| 38Weak | Apellis Pharmaceuticals, Inc. | $77k 2,685 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | APLS Apellis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -695 | $29.52 | $21k | 84,050 | Jan 30, 2025 |
| Jan 22, 2025 | APLS Apellis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -3,323 | $30.43 | $101k | 84,745 | Jan 23, 2025 |
| Jan 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,201 | $29.96 | $66k | 88,068 | Jan 21, 2025 |
| Jan 13, 2025 | APLS Apellis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,685 | $28.70 | $77k | 90,269 | Jan 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.